Medicaid Provider Spending

$1.09 trillion in Medicaid claims data, 2018–2024 · 617K+ providers
Home › MI › WYANDOTTE › HENRY FORD WYANDOTTE HOSPITAL

HENRY FORD WYANDOTTE HOSPITAL

NPI: 1992725352 · WYANDOTTE, MI 48192 · General Acute Care Hospital · NPI assigned 07/20/2006

Billing Flags · Automated signals — not evidence of fraud
Entity Proliferation

Authorized official DAMSCHRODER, ROBIN controls 14+ related entities in our dataset. Read more

$60.54M
Total Medicaid Paid
1,468,158
Total Claims
1,318,801
Beneficiaries
330
Codes Billed
2018-01
First Month
2024-12
Last Month

Provider Details

Authorized OfficialDAMSCHRODER, ROBIN (EVP, CHIEF FIN & BUS DEV OFFICER)
NPI Enumeration Date07/20/2006

Related Entities

Other providers sharing the same authorized official: DAMSCHRODER, ROBIN

ProviderCityStateTotal Paid
HENRY FORD HEALTH SYSTEM DETROIT MI $334.91M
HENRY FORD HEALTH ST. JOHN HOSPITAL CHICAGO IL $159.41M
HENRY FORD HEALTH PROVIDENCE HOSPITAL NOVI MI $72.76M
HENRY FORD HEALTH MACOMB OAKLAND HOSPITAL WARREN MI $59.25M
W.A. FOOTE MEMORIAL HOSPITAL JACKSON MI $41.32M
HENRY FORD MACOMB HOSPITAL CORPORATION CLINTON TWP MI $40.96M
HENRY FORD HEALTH GENESYS HOSPITAL GRAND BLANC MI $31.39M
HENRY FORD HEALTH MACOMB OAKLAND HOSPITAL MADISON HEIGHTS MI $24.76M
HENRY FORD HEALTH SYSTEM WEST BLOOMFIELD MI $19.27M
HENRY FORD HEALTH ROCHESTER HOSPITAL ROCHESTER MI $11.98M
HENRY FORD HEALTH RIVER DISTRICT HOSPITAL EAST CHINA MI $4.59M
W.A. FOOTE MEMORIAL HOSPITAL JACKSON MI $2.11M
HENRY FORD HEALTH PROVIDENCE HOSPITAL NOVI MI $255K
HENRY FORD HEALTH ST. JOHN HOSPITAL DETROIT MI $4K

Monthly Spending Trend

Yearly Breakdown

YearClaimsTotal Paid
2018 191,854 $8.43M
2019 200,136 $7.78M
2020 167,725 $6.53M
2021 216,224 $8.02M
2022 250,069 $9.93M
2023 248,781 $10.56M
2024 193,369 $9.29M

Billing Codes

CodeDescriptionClaimsBeneficiariesTotal Paid
99285 Emergency department visit for the evaluation and management, high severity with immediate threat to life 63,350 58,460 $19.86M
99284 Emergency department visit for the evaluation and management, high severity 39,637 37,833 $6.79M
99283 Emergency department visit for the evaluation and management, moderate severity 50,539 48,574 $5.81M
96374 Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance 39,471 36,723 $3.84M
G0378 Hospital observation service, per hour 10,276 9,105 $2.56M
87636 Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B 27,782 26,464 $2.01M
96361 Intravenous infusion, hydration; each additional hour 34,990 30,559 $1.67M
74177 Computed tomography, abdomen and pelvis; with contrast material 9,763 9,547 $1.39M
G0463 Hospital outpatient clinic visit for assessment and management of a patient 18,272 14,317 $1.27M
99291 Critical care, evaluation and management of the critically ill patient, first 30-74 minutes 2,497 2,461 $1.15M
96360 Intravenous infusion, hydration; initial, 31 minutes to 1 hour 9,454 9,228 $1.04M
99282 Emergency department visit for the evaluation and management, low to moderate severity 12,394 12,178 $890K
70450 Computed tomography, head or brain; without contrast material 8,304 7,999 $781K
96375 Therapeutic injection; each additional sequential IV push 28,551 24,634 $772K
96365 Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour 7,390 7,003 $695K
71045 Radiologic examination, chest; single view 17,550 16,767 $673K
71046 Radiologic examination, chest; 2 views 17,948 17,328 $598K
59025 Fetal non-stress test 6,393 2,344 $563K
76811 Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation, detailed 3,467 3,382 $421K
74176 Computed tomography, abdomen and pelvis; without contrast material 3,678 3,610 $381K
43239 Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple 999 993 $361K
80061 Lipid panel 7,366 7,295 $338K
76830 Ultrasound, transvaginal 5,118 4,943 $290K
76856 Ultrasound, pelvic (nonobstetric), real time with image documentation; complete 5,587 5,415 $271K
76805 Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation 4,041 3,643 $248K
97110 Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion 10,759 3,303 $246K
96372 Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular 30,718 23,814 $223K
76700 Ultrasound, abdominal, real time with image documentation; complete 3,652 3,603 $221K
71275 Computed tomographic angiography, chest, with contrast material 2,315 2,267 $219K
U0002 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc 9,537 9,105 $216K
76801 3,298 3,091 $197K
93306 Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete 1,622 1,607 $176K
93975 1,522 1,487 $171K
70553 Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences 723 720 $166K
77067 Screening mammography, bilateral, including computer-aided detection 3,108 3,107 $156K
76705 Ultrasound, abdominal, real time with image documentation; limited 2,617 2,568 $151K
90792 Psychiatric diagnostic evaluation with medical services 3,202 2,970 $144K
71260 Computed tomography, thorax, diagnostic; with contrast material 1,233 1,215 $127K
72148 Magnetic resonance imaging, lumbar spine; without contrast material 1,283 1,278 $126K
97112 Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination 5,175 1,905 $117K
U0003 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r 2,561 2,449 $115K
70496 1,567 1,547 $113K
47562 42 42 $109K
87491 Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe 8,084 7,992 $104K
87591 Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe 7,968 7,878 $97K
99281 Emergency department visit for the evaluation and management, self-limited or minor 2,005 1,970 $92K
93971 1,732 1,680 $92K
76770 1,548 1,533 $91K
10060 991 955 $91K
96366 Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour 3,442 2,869 $90K
78452 Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress 603 597 $90K
72141 626 623 $85K
97530 Therapeutic activities, direct patient contact, each 15 minutes 4,030 1,962 $84K
93970 923 909 $79K
97161 1,345 1,323 $75K
80053 Comprehensive metabolic panel 44,239 39,436 $68K
45380 Colonoscopy, flexible; with biopsy, single or multiple 148 147 $65K
84443 Thyroid stimulating hormone (TSH) 12,867 12,608 $63K
76642 1,423 1,412 $58K
73721 Magnetic resonance imaging, any joint of lower extremity; without contrast material 351 347 $50K
97162 940 922 $49K
85025 Blood count; complete (CBC), automated, and automated differential WBC count 85,133 73,631 $48K
97140 Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) 3,024 1,268 $45K
86900 8,139 7,753 $44K
82306 Vitamin D; 25 hydroxy, includes fraction(s), if performed 3,411 3,390 $44K
80307 Drug test(s), presumptive, any number of drug classes; immunoassay 11,589 10,873 $41K
70491 361 359 $36K
90471 Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine 3,655 3,543 $33K
77063 Screening digital breast tomosynthesis, bilateral 2,417 2,417 $32K
95810 Polysomnography; sleep staging with 4 or more additional parameters 58 58 $32K
86780 3,069 3,049 $31K
97165 814 799 $31K
87389 Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies 3,521 3,498 $29K
83036 Hemoglobin; glycosylated (A1C) 6,835 6,760 $29K
76881 449 403 $28K
70486 998 988 $27K
72100 2,649 2,566 $26K
C9803 Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source 27,914 26,563 $26K
72125 Computed tomography, cervical spine; without contrast material 3,426 3,330 $25K
J7120 Ringers lactate infusion, up to 1000 cc 335 308 $24K
Q3014 Telehealth originating site facility fee 1,440 1,334 $23K
70551 Magnetic resonance imaging, brain; without contrast material 252 250 $23K
93005 Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report 40,329 35,915 $22K
Q0111 Wet mounts, including preparations of vaginal, cervical or skin specimens 2,492 2,453 $22K
80048 Basic metabolic panel (calcium, ionized) 51,548 43,187 $21K
0012A 514 514 $20K
0011A 529 529 $20K
C8929 Transthoracic echocardiography with contrast, or without contrast followed by with contrast, real-time with image documentation (2d), includes m-mode recording, when performed, complete, with spectral doppler echocardiography, and with color flow doppler echocardiography 174 173 $20K
82607 3,285 3,251 $17K
84702 24,422 21,976 $16K
U0005 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 924 896 $16K
87624 Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types 790 790 $15K
58558 13 13 $15K
84439 4,032 3,981 $15K
77065 Tomosynthesis, mammo 315 289 $14K
87635 Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe 361 342 $14K
85027 14,234 12,498 $14K
93458 12 12 $14K
93976 280 277 $14K
96367 567 510 $14K
88305 Level IV - Surgical pathology, gross and microscopic examination 3,638 3,595 $13K
76536 257 256 $13K
77066 Tomosynthesis, mammo 205 203 $12K
88175 Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer 797 797 $12K
82728 2,093 2,025 $12K
73562 3,541 3,506 $11K
71250 180 178 $11K
86803 1,827 1,817 $11K
G0279 Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066) 819 808 $10K
83735 48,562 40,607 $9K
82270 324 316 $9K
82746 1,572 1,554 $9K
73630 4,171 4,090 $9K
87340 2,492 2,472 $9K
87086 Culture, bacterial; quantitative colony count, urine 9,286 8,966 $9K
83550 2,159 2,122 $9K
76817 Ultrasound, pregnant uterus, real time with image documentation, transvaginal 1,811 1,604 $9K
85610 19,851 17,594 $9K
73030 2,795 2,757 $8K
88342 1,516 1,504 $8K
29515 115 113 $8K
72131 247 245 $8K
83540 2,315 2,275 $7K
73610 3,503 3,435 $7K
87808 784 777 $7K
83880 8,663 8,223 $6K
70498 1,465 1,448 $6K
73130 3,767 3,699 $6K
73502 1,386 1,348 $6K
74018 964 907 $6K
87502 Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets 4,800 4,718 $5K
G0328 Colorectal cancer screening; fecal occult blood test, immunoassay, 1-3 simultaneous 565 557 $5K
G8978 Mobility: walking & moving around functional limitation, current status, at therapy episode outset and at reporting intervals 67 63 $5K
82570 2,307 2,159 $5K
74022 1,854 1,816 $5K
86850 8,057 7,678 $4K
G0472 Hepatitis c antibody screening, for individual at high risk and other covered indication(s) 147 147 $4K
86140 3,916 3,554 $4K
86762 1,042 1,038 $4K
36415 Collection of venous blood by venipuncture 2,349 1,910 $4K
85730 16,997 15,502 $4K
87661 Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe 2,161 2,143 $4K
G0480 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed 6,460 5,398 $4K
82105 529 516 $4K
82947 995 989 $4K
0001A 105 105 $4K
76815 Ultrasound, pregnant uterus, real time with image documentation, limited 773 692 $4K
73110 2,188 2,155 $4K
87081 8,004 7,883 $4K
81025 12,401 12,045 $3K
82565 949 839 $3K
82248 26,888 24,470 $3K
86787 867 864 $3K
81001 24,278 23,143 $3K
71271 53 53 $3K
0002A 81 81 $3K
84550 2,598 2,423 $3K
87634 2,484 2,418 $3K
86003 40 40 $3K
87631 2,032 2,000 $3K
94640 Pressurized or nonpressurized inhalation treatment for acute airway obstruction 7,466 5,630 $3K
83615 2,069 1,816 $3K
G0123 Screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, screening by cytotechnologist under physician supervision 223 222 $3K
82043 820 817 $3K
87186 2,534 2,491 $2K
72050 149 147 $2K
90686 142 141 $2K
87210 1,886 1,801 $2K
G0008 Administration of influenza virus vaccine 328 325 $2K
82550 3,061 2,749 $2K
84100 5,726 4,362 $2K
73080 1,311 1,302 $2K
84403 140 139 $2K
93017 734 726 $2K
80076 626 566 $2K
86592 120 119 $2K
87077 1,817 1,788 $2K
85652 2,133 1,982 $2K
90791 Psychiatric diagnostic evaluation 134 126 $2K
64400 13 13 $2K
86901 8,139 7,755 $2K
85007 3,211 2,902 $1K
72170 880 871 $1K
71101 440 436 $1K
83690 25,978 24,046 $1K
84156 1,279 1,125 $1K
83970 76 74 $1K
86039 255 251 $1K
81003 10,103 9,833 $1K
83655 172 172 $1K
80074 122 118 $1K
73590 1,115 1,102 $1K
83020 305 303 $1K
93880 26 26 $1K
84481 94 94 $1K
72128 13 13 $940.74
84450 445 415 $889.62
76882 37 37 $881.57
84460 423 398 $860.46
76820 1,626 1,247 $840.90
84484 23,124 19,810 $820.50
87420 2,345 2,321 $778.51
85651 795 708 $729.02
85379 6,556 6,397 $710.68
87088 845 836 $681.72
84146 66 66 $666.87
97116 52 25 $649.42
80164 483 437 $647.35
83001 67 67 $645.91
90658 35 35 $619.52
82803 7,005 6,511 $569.24
73090 982 973 $561.30
97803 64 61 $559.13
88142 43 43 $556.87
72040 78 78 $550.89
82962 15,214 10,603 $549.13
87070 466 455 $532.16
86480 13 13 $502.85
72072 56 56 $501.16
51798 1,029 786 $446.57
82784 41 38 $430.29
88341 14 14 $426.77
86038 57 56 $325.81
87205 555 541 $316.91
82140 654 594 $315.81
82077 4,858 4,491 $293.45
Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml 491 416 $275.60
87880 Infectious agent antigen detection by immunoassay; Streptococcus, group A 9,987 9,802 $262.11
89060 147 137 $261.82
88304 786 782 $254.67
86160 28 26 $231.79
83002 26 26 $231.25
87040 2,757 2,594 $227.06
83605 7,968 7,103 $213.74
82670 13 13 $208.64
J2272 Injection, morphine sulfate (fresenius kabi), not therapeutically equivalent to j2270, up to 10 mg 223 124 $199.28
93296 12 12 $198.42
29125 541 530 $185.16
12001 1,293 1,272 $184.51
86255 29 27 $178.37
86308 812 800 $171.24
85045 138 129 $168.83
G0103 Prostate cancer screening; prostate specific antigen test (psa) 12 12 $149.95
87147 217 215 $148.83
84153 13 13 $140.50
84520 88 82 $136.34
76870 221 213 $129.46
80143 1,392 1,345 $129.44
83721 20 19 $129.30
84703 9,338 8,781 $123.83
84480 13 13 $120.62
J2359 Injection, olanzapine, 0.5 mg 20 12 $103.60
12011 496 491 $100.76
71100 38 38 $99.83
85384 27 26 $81.52
96376 11,965 7,103 $75.00
76813 283 283 $73.84
84165 13 12 $67.68
80179 1,323 1,289 $58.00
73060 131 127 $52.20
73552 39 38 $48.48
82010 1,136 1,000 $47.71
82150 14 13 $42.72
70360 12 12 $34.12
86431 14 14 $33.54
73140 69 69 $33.43
85018 45 41 $32.03
J0665 Injection, bupivicaine, not otherwise specified, 0.5 mg 352 203 $28.27
83090 229 227 $21.65
84145 185 175 $17.93
J1885 Injection, ketorolac tromethamine, per 15 mg 5,436 4,863 $6.77
J1836 Injection, metronidazole, 10 mg 77 50 $6.57
J1200 Injection, diphenhydramine hcl, up to 50 mg 6,744 5,980 $4.16
C9113 Injection, pantoprazole sodium, per vial 3,513 2,041 $1.93
J0696 Injection, ceftriaxone sodium, per 250 mg 1,083 867 $1.89
J2405 Injection, ondansetron hydrochloride, per 1 mg 5,177 4,301 $1.56
G1004 Clinical decision support mechanism national decision support company, as defined by the medicare appropriate use criteria program 18,068 15,235 $1.48
90715 957 951 $0.00
J3475 Injection, magnesium sulfate, per 500 mg 61 55 $0.00
C1729 Catheter, drainage 333 292 $0.00
J2270 Injection, morphine sulfate, up to 10 mg 1,162 862 $0.00
C1758 Catheter, ureteral 392 385 $0.00
99152 182 179 $0.00
J1050 Injection, medroxyprogesterone acetate, 1 mg 437 436 $0.00
91300 208 186 $0.00
J1596 Injection, glycopyrrolate, 0.1 mg 451 436 $0.00
G8979 Mobility: walking & moving around functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting 83 76 $0.00
93325 39 39 $0.00
93356 598 597 $0.00
C1760 Closure device, vascular (implantable/insertable) 44 43 $0.00
J1644 Injection, heparin sodium, per 1000 units 32 12 $0.00
A9575 Injection, gadoterate meglumine, 0.1 ml 358 271 $0.00
90838 13 13 $0.00
J2919 Injection, methylprednisolone sodium succinate, 5 mg 15 12 $0.00
C1887 Catheter, guiding (may include infusion/perfusion capability) 25 25 $0.00
C1765 Adhesion barrier 12 12 $0.00
C1894 Introducer/sheath, other than guiding, other than intracardiac electrophysiological, non-laser 25 24 $0.00
C1713 Anchor/screw for opposing bone-to-bone or soft tissue-to-bone (implantable) 13 13 $0.00
J1756 Injection, iron sucrose, 1 mg 16 13 $0.00
J3490 Unclassified drugs 3,836 2,711 $0.00
12002 140 138 $0.00
Q0162 Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen 744 695 $0.00
J1100 Injection, dexamethasone sodium phosphate, 1 mg 9,937 9,424 $0.00
J2704 Injection, propofol, 10 mg 1,730 1,438 $0.00
J2003 Injection, lidocaine hydrochloride, 1 mg 237 223 $0.00
J1630 Injection, haloperidol, up to 5 mg 38 25 $0.00
C1769 Guide wire 559 544 $0.00
J1920 Injection, labetalol hydrochloride, 5 mg 13 12 $0.00
91301 1,041 1,009 $0.00
J7121 5% dextrose in lactated ringers infusion, up to 1000 cc 33 27 $0.00
J2785 Injection, regadenoson, 0.1 mg 464 458 $0.00
J2470 Injection, pantoprazole sodium, 40 mg 327 207 $0.00
96368 68 65 $0.00
J3010 Injection, fentanyl citrate, 0.1 mg 1,999 1,794 $0.00
J2250 Injection, midazolam hydrochloride, per 1 mg 1,395 1,300 $0.00
36410 93 88 $0.00
A9500 Technetium tc-99m sestamibi, diagnostic, per study dose 79 79 $0.00
J2001 Injection, lidocaine hcl for intravenous infusion, 10 mg 101 101 $0.00
J2790 Injection, rho d immune globulin, human, full dose, 300 micrograms (1500 i.u.) 175 174 $0.00
87430 143 140 $0.00
J2060 Injection, lorazepam, 2 mg 48 31 $0.00
J2765 Injection, metoclopramide hcl, up to 10 mg 44 42 $0.00
80178 14 12 $0.00
84132 16 14 $0.00
36416 13 12 $0.00
J1815 Injection, insulin, per 5 units 40 25 $0.00
J1817 Insulin for administration through dme (i.e., insulin pump) per 50 units 164 89 $0.00
G8980 Mobility: walking & moving around functional limitation, discharge status, at discharge from therapy or to end reporting 40 38 $0.00
96127 19 19 $0.00
88307 12 12 $0.00